Inflammatory stress signaling via NF-kB alters accessible cholesterol to upregulate SREBP2 transcriptional activity in endothelial cells

Abstract

There is a growing appreciation that a tight relationship exists between cholesterol homeostasis and immunity in leukocytes, however, this relationship has not been deeply explored in the vascular endothelium. Endothelial cells (ECs) rapidly respond to extrinsic signals, such as tissue damage or microbial infection, by upregulating factors to activate and recruit circulating leukocytes to the site of injury and aberrant activation of ECs leads to inflammatory based diseases, such as multiple sclerosis and atherosclerosis. Here, we studied the role of cholesterol and a key transcription regulator of cholesterol homeostasis, SREBP2, in the EC responses to inflammatory stress. Treatment of primary human ECs with pro-inflammatory cytokines upregulated SREBP2 cleavage and cholesterol biosynthetic gene expression within the late phase of the acute inflammatory response. Furthermore, SREBP2 activation was dependent on NF-kB DNA binding and canonical SCAP-SREBP2 processing. Mechanistically, inflammatory activation of SREBP was mediated by a reduction in accessible cholesterol, leading to heightened sterol sensing and downstream SREBP2 cleavage. Detailed analysis of NF-kB inducible genes that may impact sterol sensing resulted in the identification of a novel RELA-inducible target, STARD10, that mediates accessible cholesterol homeostasis in ECs. Thus, this study provides an in-depth characterization of the relationship between cholesterol homeostasis and the acute inflammatory response in EC.

Data availability

Sequencing data have been deposited in GEO under accession code GSE201466.All data generated or analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for all figures.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Joseph Wayne M Fowler

    Department of Pharmacology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Rong Zhang

    Department of Pharmacology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Bo Tao

    Department of Pharmacology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Nabil E Boutagy

    Department of Pharmacology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. William C Sessa

    Department of Pharmacology, Yale University, New Haven, United States
    For correspondence
    william.sessa@yale.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5759-1938

Funding

NIH

  • William C Sessa

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animals were handed according to approved institutional animal care and use committee (IACUC) protocols (#07919-2020) of Yale University.

Copyright

© 2022, Fowler et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Joseph Wayne M Fowler
  2. Rong Zhang
  3. Bo Tao
  4. Nabil E Boutagy
  5. William C Sessa
(2022)
Inflammatory stress signaling via NF-kB alters accessible cholesterol to upregulate SREBP2 transcriptional activity in endothelial cells
eLife 11:e79529.
https://doi.org/10.7554/eLife.79529

Share this article

https://doi.org/10.7554/eLife.79529